Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Conference News TCT 2025

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

Yael L. Maxwell

October 27, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2023

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Yael L. Maxwell

November 02, 2023

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

News Conference News TCT 2022

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

Yael L. Maxwell

September 17, 2022

News Conference News TCT 2022

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Michael O'Riordan

September 17, 2022

News Conference News TCT 2021

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

Yael L. Maxwell

November 06, 2021

News Conference News TCT 2019

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Shelley Wood

September 28, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Shelley Wood

September 28, 2019

News Conference News TCT 2019

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Yael L. Maxwell

September 27, 2019

News Conference News TCT 2019

Learning Curve Exists for MitraClip, Volume-Outcomes Data Hint

Todd Neale

September 27, 2019

News Opinion Editor's Corner TCT 2018

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

Shelley Wood

October 12, 2018

News Conference News TCT 2018

Transcatheter Mitral Valve Repair Provides Fast, Sustained Gains in Quality of Life

TCT Daily Staff

September 27, 2018

News Conference News TCT 2018

COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF

Shelley Wood

September 23, 2018

News Conference News TCT 2017

Valve-in-Ring, Valve-in-MAC TMVR Procedures Feasible, but Patient Selection Is Key

Yael L. Maxwell

November 10, 2017

News Conference News TCT 2017

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Yael L. Maxwell

November 01, 2017

Presentation TCT 2014

Heart Team Decisions: Who Is the Appropriate Prohibitive-Risk DMR Patient for MitraClip?

Presenter: Olaf Franzen, James B. Hermiller Jr, Michael J. Rinaldi, Gorav Ailawadi

September 13, 2014

Presentation TCT 2014

Cardiologist's Perspective: How I Use the Anatomical and Hemodynamic Data in MitraClip Clinical Decision Making

Presenter: Thomas H. Maloney, John R. Zimmerman, Michael J. Rinaldi

September 13, 2014

Presentation TCT 2013

Understanding the FDA Panel Decision to Approve MitraClip

Presenter: Mitchell Krucoff

October 30, 2013

News Conference News TCT 2013

ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR

October 30, 2013

Advertisement

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

What’s Going to Be Hot at TCT 2025

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Learning Curve Exists for MitraClip, Volume-Outcomes Data Hint

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

Transcatheter Mitral Valve Repair Provides Fast, Sustained Gains in Quality of Life

COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF

Valve-in-Ring, Valve-in-MAC TMVR Procedures Feasible, but Patient Selection Is Key

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Heart Team Decisions: Who Is the Appropriate Prohibitive-Risk DMR Patient for MitraClip?

Cardiologist's Perspective: How I Use the Anatomical and Hemodynamic Data in MitraClip Clinical Decision Making

Understanding the FDA Panel Decision to Approve MitraClip

ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content